Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases

European Journal of Cancer

Volumn 34, Issue SUPPL. 3, 1998, Pages

  Ross, M I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lymphatic mapping; Melanoma; Prognostic factors; Sentinel node biopsy

Indexed keywords

AZURIN; DYE; SULFUR;

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MELANOMA; PRIORITY JOURNAL;

BIOPSY; CLINICAL TRIALS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SURVIVAL RATE;

EID: 0031660892     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Balch CM, Soong S-J, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 1981, 193, 377-388.
2. Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol 1997, 24(Suppl. 4), S4-S8-S4-10.
3. Balch CM, Soong S-J, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996, 224, 255-266.
4. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986, 61, 697-705.
5. Reintgen DS, Cox EB, McCarty KM Jr, et al. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983, 198, 379-385.
6. Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993, 9, 219-223.
7. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982, 49, 2420-2430.
8. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684. J Clin Oncol 1996, 14, 7-17.
9. Balch CM, Soong S-J, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, U.S.A., and New South Wales, Australia. Ann Surg 1982, 196, 677-684.
10. Morton DL, Wen D-R, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck. J Clin Oncol 1993, 11, 1751-1756.
11. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127, 392-399.
12. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994, 220, 759-767.
13. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radio-lymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996, 223, 217-224.
14. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in the regional lymph nodes. Melanoma Res 1995, 5, 255-260.
15. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996, 276, 1818-1822.
16. Reintgen DS, Conrad AJ. Detection of occult melanoma cells in sentinel lymph nodes and blood. Semin Oncol 1997, 24(Suppl 4), S4-S5.